Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
| Image |  |
|---|---|
| Description | scientific article published on 14 November 2012 |
| Author/s |
author: Fabrizio Vianello Luca Baldini |
| Publication date | November 14, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |